Avian reticuloendotheliosis virus: identification of the hematopoietic target cell for transformation.
Non-virus-producing hematopoietic cells transformed in vitro by reticuloendotheliosis virus (REV-T) induce lethal "reticuloendotheliosis" when inoculated into histocompatible chickens. This is the first direct demonstration that an in vivo target cell of an avian acute leukemia virus can be transformed in vitro. The tumorigenic, REV-T-transformed non-virus-producing cells fail to express helper-virus-coded proteins. REV-T transformed tumorigenic cells therefore do not require helper-virus functions. Cells transformed in vivo or in vitro by REV-T have lymphoblastoid morphology and express low levels of terminal-deoxynucleotidyl-transferase activity and bursal-cell determinants. One clone synthesized Ig mu. The preferred target cells for REV-T transformation are therefore immature lymphoid cells that express B-cell determinants. We propose that the unique transforming sequence of REV-T be designated rel (lymphoid).
D000818:Animals; D002460:Cell Line; D002471:Cell Transformation, Neoplastic; D002472:Cell Transformation, Viral; D002645:Chickens; D004253:DNA Nucleotidylexotransferase / Q000378:metabolism; D006378:Helper Viruses / Q000502:physiology; D006410:Hematopoiesis; D007136:Immunoglobulins / Q000096:biosynthesis; D008206:Lymphatic Diseases / Q000209:etiology; D008214:Lymphocytes / Q000382:microbiology*; D001356:Reticuloendotheliosis virus / Q000502:physiology*; D012190:Retroviridae / Q000502:physiology*; D014412:Tumor Virus Infections / Q000209:etiology
D007136:Immunoglobulins; D004253:DNA Nucleotidylexotransferase